Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. - sprookjes - yvandenbroek - TriplyDB

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

http://www.wikidata.org/entity/Q34077644

about

Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in men Current status of carotid ultrasound in atherosclerosis Multimodality Imaging in Coronary Artery Disease: Focus on Computed Tomography Coronary artery calcification in clinical practice: what we have learned and why should it routinely be reported on chest CT?Ethnic Minorities and Coronary Heart Disease: an Update and Future Directions Reassessing the Usefulness of Coronary Artery Calcium Score among Varying Racial and Ethnic Groups by Geographic Locations: Relevance of the Korea Initiatives on Coronary Artery Calcification Registry Cardiovascular Imaging for the Primary Prevention of Atherosclerotic Cardiovascular Disease Events A New Approach in Risk Stratification by Coronary CT Angiography Using advanced noninvasive imaging techniques to probe the links between regional coronary artery endothelial dysfunction and atherosclerosis Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease?The Year in Cardiology 2012: focus on cardiovascular disease prevention Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines Screening for Ischemic Heart Disease with Cardiac CT: Current Recommendations Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of Atherosclerosis.Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease New insights from major prospective cohort studies with cardiac CT Subclinical atherosclerosis measures for cardiovascular prediction in CKD Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts Heart disease and stroke statistics--2014 update: a report from the American Heart Association Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Early Detection System of Vascular Disease and Its Application Prospect Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.A functionally significant polymorphism in ID3 is associated with human coronary pathology Molecular imaging in cardiovascular disease: Which methods, which diseases?Cardiovascular risk assessment in patients with diabetes.Baseline subclinical atherosclerosis burden and distribution are associated with frequency and mode of future coronary revascularization: multi-ethnic study of atherosclerosis Calcium density of coronary artery plaque and risk of incident cardiovascular events Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trial.Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension.Role of computed tomography for diagnosis and risk stratification of patients with suspected or known coronary artery disease.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis Intima media thickness, pulse wave velocity, and flow mediated dilation.Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients.Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis Low-density lipoprotein electronegativity is a novel cardiometabolic risk factor

P2860

Q23918985-0F8CA8EC-FE43-4765-B099-7982DE577D73 Q26739732-F54F47A5-084F-41AA-B0D6-B7BE7B2D0D6F Q26747757-C4D21C10-1CD9-4898-853F-F020535D6108 Q26747779-2C1D2561-921F-4281-B5E5-816E47419D71 Q26770594-164E6A24-ABDC-400D-BAA1-272EE9009F2E Q26772283-FE0A2DC2-565F-440A-BD47-13CDB2F93AFA Q26795419-1050A710-2DEA-4794-9828-FC05626C5AE6 Q26828516-8E989B90-49CF-438E-A0A0-774B0A46C19A Q26829688-D937DF49-5504-44C6-B860-63E2BAF6770A Q26830867-B00C13AA-DABF-4594-893A-322B054B2C1A Q26851148-F2C49EFD-71A9-477E-B9A0-A4520CA5E635 Q26860929-64F6F12A-2CDC-4978-8BE1-85EF760DDD17 Q26991787-406C0B76-CA3A-4C04-908D-E1035395FACB Q27009480-FC2C0535-FB04-475C-B40E-435C3E771875 Q27026486-BCD378B7-AB44-4583-A48F-8B2A36A5F8C9 Q27340038-EC6F466F-50E9-42E6-BC46-632F5A51E3C7 Q28066080-BD202F94-AE2E-4636-BC37-4A0AE1A28C07 Q28084463-7B224561-3D0B-43EF-B060-BE8A4FAE2CEF Q28386933-889CD594-9499-46EC-A6F8-F04DB00052AB Q28686330-FB63171B-2CF6-4954-B9F8-8ADF823E8053 Q29547691-BF9695DA-2B6C-4DE6-BB19-03887BB9C245 Q30238784-89DC86E6-9273-4B38-A1D9-07D2D3FCD1DF Q30239836-BBF73A9A-53B1-4D6B-B345-FE48B5C41676 Q30277401-1D776A97-5859-4487-BA0C-AE598BB686A3 Q30278617-4324799D-8A67-4E7C-9BB7-5823665425E6 Q30414349-38525443-5EF7-4582-A4FE-D592E36D6469 Q30442045-95EFF21A-C655-4676-9D5E-2F0D269B2CF5 Q33582582-891CED28-71DB-4071-A538-9C0BFFD995F4 Q33626995-76A599B0-B660-41D0-B763-5A3A88460F11 Q33880394-66CDDE5E-E9A1-4FB2-9A04-D1691AD1787D Q33880418-BE9A3D72-5174-4BE5-A601-E2059EC82E19 Q33899641-753F002A-15F0-42AD-8833-7CE07F1FC56D Q33959468-5605AF72-95AA-4043-B2E6-C2E94A9902DD Q33995007-764BA1CC-23C5-4450-A51B-0E409DA17EFC Q34046881-597064C1-FF65-4E42-8833-E671157FEB71 Q34115861-0FC42BB0-1FF0-4D49-AFAF-057C85E3CA60 Q34130734-4F21D6CC-3869-4462-9DDE-E720C79CFB16 Q34133250-E44D609C-D918-4C97-B6EB-CA4482E2408A Q34143079-05A06A55-6D56-4159-941B-61B24DE76FA6 Q34156161-19391450-2C8C-4E2F-9E3A-0BD38FE03EAF

P2860

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

http://www.wikidata.org/entity/Q34077644

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Comparison of novel risk marke ...... intermediate-risk individuals.

@ast

Comparison of novel risk marke ...... intermediate-risk individuals.

@en

Comparison of novel risk marke ...... intermediate-risk individuals.

@nl

type

label

Comparison of novel risk marke ...... intermediate-risk individuals.

@ast

Comparison of novel risk marke ...... intermediate-risk individuals.

@en

Comparison of novel risk marke ...... intermediate-risk individuals.

@nl

prefLabel

Comparison of novel risk marke ...... intermediate-risk individuals.

@ast

Comparison of novel risk marke ...... intermediate-risk individuals.

@en

Comparison of novel risk marke ...... intermediate-risk individuals.

@nl

P1433

Q34077644-3E3F211E-F047-433E-8579-C7A8C2B3C383

P1476

Q34077644-267FDD42-CE80-497B-B8CD-D18A6D8AE9A4

P2093

Q34077644-07964E2A-5779-4701-BA2B-FA70410997A7

Q34077644-20EBDBD6-1BB4-4721-BF0E-79CD2E4AC1F5

Q34077644-324C2804-9D43-4252-B640-36769612A24C

Q34077644-46B4A54B-F95B-4E91-900E-04D5F47B5E50

Q34077644-4A77D6D2-2617-40BA-81DC-5DA2253611B1

Q34077644-637F417F-C383-42ED-AB8E-247B690CDB8D

Q34077644-CD017B2C-3F23-47CB-86FA-86F681B4592A

Q34077644-F205A57C-706B-47FF-868C-E20FD96E5D4A

Q34077644-FB080389-EDB7-44B3-88CA-AFDC2C8575F1

P2860

Q34077644-0016EF99-FADF-4AC4-8D55-6C63CE44322D

Q34077644-0E79BDE8-DEAE-4307-814A-46B9EE34B8EA

Q34077644-1EC0FC77-8C32-4532-8956-3C394CC08761

Q34077644-233DBE0A-09FC-4A7C-AAC3-8CF9B5CF0B11

Q34077644-23B8E388-0C04-410C-A066-8653A10F5FC9

Q34077644-2B509BD8-8FA8-4883-BFC5-768D9DABD868

Q34077644-301C0DF7-A9BD-4427-9786-AE2FACABB6F1

Q34077644-36946B19-A698-4EC1-AA72-B30FFD0034EC

Q34077644-3D6B33BD-2BFC-4087-827C-2F71D5372947

Q34077644-47A5702F-13AB-4FCD-97BE-9454554FC812

P304

Q34077644-A24ADC14-ACE7-45D4-9B83-E6AE7E75546A

P31

Q34077644-DC904135-11D6-48E4-B283-44C6D5FF91D8

P356

Q34077644-C12EA66E-D39C-490B-B9D9-CBEC456EB50D

P407

Q34077644-1BAC3A2D-8656-4EE8-9DF4-EF3DD663ECA2

P433

Q34077644-D66E9FB8-56B2-416E-99A0-D9DB3128E8B2

P478

Q34077644-D47FEFF1-F133-4402-B7B7-0795C341ED41

P50

Q34077644-4A62E2F5-2839-4F7A-8F6F-CD409483F4C9

P577

Q34077644-B3B373D1-B369-4B38-9376-4FBDB256899D

P698

Q34077644-55E22211-183D-4244-81F2-909626585A07

P921

Q34077644-DBC41C01-6033-478E-AE13-8742C5CBD359

P932

Q34077644-0326E8D3-FC1E-47F7-A4E6-8841BD6C7A58

P356

P1433

Journal of the American Medical Association

P1476

Comparison of novel risk marke ...... intermediate-risk individuals

@en

P2093

Christopher T Sibley

http://www.w3.org/2001/XMLSchema#string

Daniel O'Leary

http://www.w3.org/2001/XMLSchema#string

David C Goff

http://www.w3.org/2001/XMLSchema#string

David M Herrington

http://www.w3.org/2001/XMLSchema#string

Gregory L Burke

http://www.w3.org/2001/XMLSchema#string

Joseph Yeboah

http://www.w3.org/2001/XMLSchema#string

Philip Greenland

http://www.w3.org/2001/XMLSchema#string

Robyn L McClelland

http://www.w3.org/2001/XMLSchema#string

Tamar S Polonsky

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Projected cancer risks from computed tomographic scans performed in the United States in 2007

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Multi-Ethnic Study of Atherosclerosis: objectives and design

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis

Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study.

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis

The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis).

The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III.

P304

788-795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2012.9624

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

308

http://www.w3.org/2001/XMLSchema#string

P50

John Jeffrey Carr

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22910756

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

4141475

http://www.w3.org/2001/XMLSchema#string